Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-Life
Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-Life
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Treatment efficacy and costs of anti-VEGF drugs have not been studied in clinical routine.
To compare treatment costs and clinical outcomes of the medications when adjusting for patients' characteristics and clinical status.
Comparative study.
The largest public ophthalmologic clinic in Switzerland.
Health care claims data of patients w...
Alternative Titles
Full title
Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-Life
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2044551602
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2044551602
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0135050
